来自Cassia nomame的甲基酸 C抑制了氧化的产生
Daiki Nagatsuka1, Tetsuya Saito2, Makoto Fujisawa1,2
1Graduate School of Food and Nutritional Sciences, Toyo University, 48-1, Oka, Asaka, Saitama 351-8510, Japan.
Bioscience, biotechnology, and biochemistry
|November 13, 2025
概括
脱甲基黄素C (DTFC) 是一种黄素衍生物,通过降低关键炎症标志物而降低巨细胞的炎症,而无毒性. DTFC显示的抗炎功效与黄素相当.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
- 免疫学 免疫学 免疫学
背景情况:
- 炎症是许多疾病的关键过程.
- 氧化 (NO) 是炎症的关键媒介.
- 卡西亚名氏衍生品正在研究治疗潜力.
研究的目的:
- 为了研究甲基托罗萨弗拉C (DTFC) 的抗炎作用.
- 确定DTFC在巨细胞中的作用机制.
- 为了比较DTFC与黄素的疗效.
主要方法:
- 用DTFC和脂多糖 (LPS) 治疗RAW264巨细胞.
- 测量了氧化 (NO) 的产量.
- 分析了可诱导氧化合成酶 (iNOS) 和循环氧化原酶-2 (COX-2) 的蛋白质和mRNA水平.
- 评估了细胞毒性.
主要成果:
- 在RAW264巨细胞中,DTFC抑制了LPS诱导的NO生产.
- DTFC没有表现出直接的NO激素清理活动.
- 在蛋白质和mRNA水平上,DTFC降低了iNOS和COX-2.
- DTFC没有显示显著的细胞毒性.
结论:
- 通过降低iNOS和COX-2的调节,DTFC具有抗炎性质.
- DTFC的抗炎途径与黄素的抗炎途径相似.
- 对于炎症状况,DTFC的治疗潜力与黄素的治疗潜力相当.
相关概念视频
Nitric Oxide Signaling Pathway
6.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.1K
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Antianginal Drugs: Nitrates and β-Blockers
1.3K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.3K
Adrenergic Agonists: Indirect-Acting Agents
2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
542
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
542


